Global Cancer Pain Therapeutics Market to grow at a CAGR of 9.08% during the period 2016 - 2020; Finds New Report

Report forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.

Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.

The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.

The market is divided into the following segments based on region:

• Americas: The US, Canada, Mexico, and Brazil
• EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
• APAC: Japan, China, Australia, Singapore, South Korea, and India

According to the report, the major driving factor for the global cancer pain therapeutics market is the high unmet need for appropriate drugs in the market.

Further, the report states that the use of off-label drugs is another important challenge for the market.

Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Cancer Pain Therapeutics Market:  BioDelivery Sciences, ProStrakan Group and Teva Pharmaceuticals

Other Prominent Vendors in the market are: Daiichi Sankyo, Eli-lilly, Galena Biopharma, Grunenthal Group, GW Pharmaceuticals, Hospira, Johnson & Johnson, Meda Pharmaceuticals, Orexo, Sanofi, Sorrento Therapeutics, and WEX Pharmaceuticals.

Market driver

• Unmet medical needs
• For a full, detailed list, view our report

Market challenge

• Off-label drug use
• For a full, detailed list, view our report

Market trend

• Increase in awareness
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 61 pages and 32 Exhibit “Global Cancer Pain Therapeutics Market 2015 - 2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Disease overview, Pipeline portfolio, Market landscape, Market segmentation by drug class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/oVY

Find all Healthcare report at : http://www.marketresearchreports.com/healthcare